Literature DB >> 2160550

Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipient.

N J Vogelzang1.   

Abstract

We report on a patient with a transplanted kidney and metastatic testicular cancer who received 4 cycles of cisplatin and etoposide. The patient experienced no renal toxicity and was free of disease after 5 years. Patient management issues are discussed.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2160550     DOI： 10.1016/s0022-5347(17)40237-0

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  1 in total

1.  The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?

Authors:  Tomas Pokrivcak; Radek Lakomy; Tomas Kazda; Alexandr Poprach; Pavel Fabian; Igor Kiss
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.